Pleiotrophin (PTN) is expressed in vascularized human atherosclerotic plaques: IFN-γ/JAK/STAT1 signaling is critical for the expression of PTN in macrophages

被引:16
|
作者
Li, Fuqiang [1 ]
Tian, Fang [1 ]
Wang, Lai [1 ]
Williamson, Ian K. [1 ]
Sharifi, Behrooz G. [1 ]
Shah, Prediman K. [1 ]
机构
[1] Cedars Sinai Med Ctr, Div Cardiol, Atherosclerosis Res Ctr, Burns & Allen Res Inst, Los Angeles, CA 90048 USA
来源
FASEB JOURNAL | 2010年 / 24卷 / 03期
基金
美国国家卫生研究院;
关键词
plaque angiogenesis; neovascularization; vasculogenic mimicry; AFFIN REGULATORY PEPTIDE; GROWTH-FACTOR PLEIOTROPHIN; HUMAN CORONARY-ARTERIES; HUMAN PROSTATE-CANCER; CELL-PROLIFERATION; ENDOTHELIAL-CELLS; INTERFERON-GAMMA; GENE-EXPRESSION; VASCULOGENIC MIMICRY; UP-REGULATION;
D O I
10.1096/fj.09-140780
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neovascularization is critical to destabilization of atheroma. We previously reported that the angiogenic growth factor pleiotrophin (PTN) coaxes monocytes to assume the phenotype of functional endothelial cells in vitro and in vivo. In this study we show that PTN expression is colocalized with capillaries of human atherosclerotic plaques. Among the various reagents that are critical to the pathogenesis of atherosclerosis, interferon (IFN)-gamma was found to markedly induce PTN mRNA expression in a dose-dependent manner in macrophages. Mechanistic studies revealed that the Janus kinase inhibitors, WHI-P154 and ATA, efficiently blocked STAT1 phosphorylation in a concentration-and time-dependent manner. Notably, the level of phosphorylated STAT1 was found to correlate directly with the PTN mRNA levels. In addition, STAT1/STAT3/p44/42 signaling molecules were found to be phosphorylated by IFN-gamma in macrophages, and they were translocated into the nucleus. Further, PTN promoter analysis showed that a gamma-activated sequence (GAS) located at -2086 to -2078 bp is essential for IFN-gamma-regulated promoter activity. Moreover, electrophoretic mobility shift, supershift, and chromatin immunoprecipitation analyses revealed that both STAT1 and STAT3 bind to the GAS at the chromatin level in the IFN-gamma stimulated cells. Finally, to test whether the combined effect of STAT1/STAT3/p44/42 signaling is required for the expression of PTN in macrophages, gene knockdowns of these transcription factors were performed using siRNA. Cells lacking STAT1, but not STAT3 or p42, have markedly reduced PTN mRNA levels. These data suggest that PTN expression in the human plaques may be in part regulated by IFN-gamma and that PTN is involved in the adaptive immunity.-Li, F., Tian, F., Wang, L., Williamson, I. K., Sharifi, B. G., Shah, P. K. Pleiotrophin (PTN) is expressed in vascularized human atherosclerotic plaques: IFN-gamma/JAK/STAT1 signaling is critical for the expression of PTN in macrophages FASEB J.24, 810-822 (2010). www.fasebj.org
引用
收藏
页码:810 / 822
页数:13
相关论文
共 50 条
  • [41] Cepharanthine Inhibits IFN-γ-Induced CXCL10 by Suppressing the JAK2/STAT1 Signal Pathway in Human Salivary Gland Ductal Cells
    Aota, Keiko
    Yamanoi, Tomoko
    Kani, Koichi
    Azuma, Masayuki
    INFLAMMATION, 2018, 41 (01) : 50 - 58
  • [42] Influence of the human endogenous retrovirus-like element HERV-E.PTN on the expression of growth factor pleiotrophin: a critical role of a retroviral Sp1-binding site
    Anke M Schulte
    Claudius Malerczyk
    Rafael Cabal-Manzano
    Jason J Gajarsa
    Heinz-Joachim List
    Anna Tate Riegel
    Anton Wellstein
    Oncogene, 2000, 19 : 3988 - 3998
  • [43] Influence of the human endogenous retrovirus-like element HERV-E.PTN on the expression of growth factor pleiotrophin: a critical role of a retroviral Sp1-binding site
    Schulte, AM
    Malerczyk, C
    Cabal-Manzano, R
    Gajarsa, JJ
    List, HJ
    Riegel, AT
    Wellstein, A
    ONCOGENE, 2000, 19 (35) : 3988 - 3998
  • [44] The I7L protein of African swine fever virus is involved in viral pathogenicity by antagonizing the IFN-γ-triggered JAK-STAT signaling pathway through inhibiting the phosphorylation of STAT1
    Li, Meilin
    Liu, Xinyuan
    Peng, Dingkun
    Yao, Meng
    Wang, Tao
    Wang, Yijing
    Cao, Hongwei
    Wang, Yanjin
    Dai, Jingwen
    Luo, Rui
    Deng, Hao
    Li, Jiaqi
    Luo, Yuzi
    Li, Yongfeng
    Sun, Yuan
    Li, Su
    Qiu, Hua-Ji
    Li, Lian-Feng
    PLOS PATHOGENS, 2024, 20 (09)
  • [45] Silencing SIRT1 promotes the anti-HBV action of IFN-α by regulating Pol expression and activating the JAK-STAT signaling pathway
    Tang, Qinyan
    Meng, Chunyan
    Liu, Yue
    Cheng, Yanlin
    Liu, Yang
    Long, Yifei
    Sun, Shufeng
    Feng, Fumin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 124
  • [46] SH2 Modified STAT1 Induces HLA-I Expression and Improves IFN-γ Signaling in IFN-α Resistant HCV Replicon Cells (Publication with Expression of Concern. See vol. 17, 2022)
    Poat, Bret
    Hazari, Sidhartha
    Chandra, Partha K.
    Gunduz, Feyza
    Balart, Luis A.
    Alvarez, Xavier
    Dash, Srikanta
    PLOS ONE, 2010, 5 (09): : 1 - 14
  • [47] Human metapneumovirus small hydrophobic (SH) protein downregulates type I IFN pathway signaling by affecting STAT1 expression and phosphorylation
    Hastings, Andrew K.
    Amato, Katherine R.
    Wen, Sherry C.
    Peterson, Laura S.
    Williams, John V.
    VIROLOGY, 2016, 494 : 248 - 256
  • [48] SH2 Modified STAT1 Induces HLA-I Expression and Improves IFN-γ Signaling in IFN-α Resistant HCV Replicon Cells (Expression of Concern of Vol 5, art no E13117, 2010)
    Poat, B.
    Hazari, S.
    Chandra, P. K.
    Gunduz, F.
    Balart, L. A.
    Alvarez, X.
    PLOS ONE, 2022, 17 (03):
  • [49] Dampening of IFN-γ-inducible gene expression in human choriocarcinoma cells is due to phosphatase-mediated inhibition of the JAK/STAT-1 pathway
    Choi, Jason C.
    Holtz, Renae
    Petroff, Margaret G.
    Alfaidy, Nadia
    Murphy, Shawn P.
    JOURNAL OF IMMUNOLOGY, 2007, 178 (03): : 1598 - 1607
  • [50] Illicium verum extract suppresses IFN-γ-induced ICAM-1 expression via blockade of JAK/STAT pathway in HaCaT human keratinocytes
    Sung, Yoon-Young
    Kim, Ho Kyoung
    JOURNAL OF ETHNOPHARMACOLOGY, 2013, 149 (03) : 626 - 632